| Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial | |
| Zhang, Qingyuan; Xu, Binghe; Funasaka, Setsuo; Saito, Kenichi; Hiraiwa, Masahide; Chen, Zhendong; Wang, Xiaojia; Ouyang, Quchang; Cheng, Ying; Cui, Shude | |
| 刊名 | EUROPEAN JOURNAL OF CANCER
 |
| 2019 | |
| 卷号 | 112 |
| 关键词 | Progression-free survival Tolerability Locally recurrent or metastatic breast cancer Eribulin |
| ISSN号 | 0959-8049 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3535065 |
| 专题 | 吉林大学白求恩第一医院 |
| 推荐引用方式 GB/T 7714 | Zhang, Qingyuan,Xu, Binghe,Funasaka, Setsuo,et al. Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial[J]. EUROPEAN JOURNAL OF CANCER,2019,112. |
| APA | Zhang, Qingyuan.,Xu, Binghe.,Funasaka, Setsuo.,Saito, Kenichi.,Hiraiwa, Masahide.,...&Yuan, Peng.(2019).Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial.EUROPEAN JOURNAL OF CANCER,112. |
| MLA | Zhang, Qingyuan,et al."Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial".EUROPEAN JOURNAL OF CANCER 112(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论